Literature DB >> 32315384

A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice.

Adam Miszta1,2,3, Anna K Kopec4, Asmita Pant4, Lori A Holle1, James R Byrnes1, Daniel A Lawrence5, Kirk C Hansen6, Matthew J Flick1, James P Luyendyk4, Bas de Laat2,3, Alisa S Wolberg1.   

Abstract

Obesity is a prevalent prothrombotic risk factor marked by enhanced fibrin formation and suppressed fibrinolysis. Fibrin both promotes thrombotic events and drives obesity pathophysiology, but a lack of essential analytical tools has left fibrinolytic mechanisms affected by obesity poorly defined. Using a plasmin-specific fluorogenic substrate, we developed a plasmin generation (PG) assay for mouse plasma that is sensitive to tissue plasminogen activator, α2-antiplasmin, active plasminogen activator inhibitor (PAI-1), and fibrin formation, but not fibrin crosslinking. Compared with plasmas from mice fed a control diet, plasmas from mice fed a high-fat diet (HFD) showed delayed PG and reduced PG velocity. Concurrent to impaired PG, HFD also enhanced thrombin generation (TG). The collective impact of abnormal TG and PG in HFD-fed mice produced normal fibrin formation kinetics but delayed fibrinolysis. Functional and proteomic analyses determined that delayed PG in HFD-fed mice was not due to altered levels of plasminogen, α2-antiplasmin, or fibrinogen. Changes in PG were also not explained by elevated PAI-1 because active PAI-1 concentrations required to inhibit the PG assay were 100-fold higher than circulating concentrations in mice. HFD-fed mice had increased circulating thrombomodulin, and inhibiting thrombomodulin or thrombin-activatable fibrinolysis inhibitor (TAFI) normalized PG, revealing a thrombomodulin- and TAFI-dependent antifibrinolytic mechanism. Integrating kinetic parameters to calculate the metric of TG/PG ratio revealed a quantifiable net shift toward a prothrombotic phenotype in HFD-fed mice. Integrating TG and PG measurements may define a prothrombotic risk factor in diet-induced obesity.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32315384      PMCID: PMC7205812          DOI: 10.1182/blood.2019004267

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  82 in total

1.  Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.

Authors:  Tanya M Binette; Fletcher B Taylor; Glenn Peer; Laszlo Bajzar
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

2.  Thrombin promotes diet-induced obesity through fibrin-driven inflammation.

Authors:  Anna K Kopec; Sara R Abrahams; Sherry Thornton; Joseph S Palumbo; Eric S Mullins; Senad Divanovic; Hartmut Weiler; A Phillip Owens; Nigel Mackman; Ashley Goss; Joanne van Ryn; James P Luyendyk; Matthew J Flick
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

3.  Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation.

Authors:  W Wang; M Nagashima; M Schneider; J Morser; M Nesheim
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

Review 4.  Molecular mechanisms of initiation of fibrinolysis by fibrin.

Authors:  Leonid Medved; Willem Nieuwenhuizen
Journal:  Thromb Haemost       Date:  2003-03       Impact factor: 5.249

5.  Obesity increases risk of ischemic stroke in young adults.

Authors:  Andrew B Mitchell; John W Cole; Patrick F McArdle; Yu-Ching Cheng; Kathleen A Ryan; Mary J Sparks; Braxton D Mitchell; Steven J Kittner
Journal:  Stroke       Date:  2015-05-05       Impact factor: 7.914

6.  Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies.

Authors:  M W Boehme; Y Deng; U Raeth; A Bierhaus; R Ziegler; W Stremmel; P P Nawroth
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

7.  Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defense.

Authors:  Joni M Prasad; Oleg V Gorkun; Harini Raghu; Sherry Thornton; Eric S Mullins; Joseph S Palumbo; Ya-Ping Ko; Magnus Höök; Tovo David; Shaun R Coughlin; Jay L Degen; Matthew J Flick
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

8.  Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.

Authors:  Shu-Min Lin; Yu-Min Wang; Horng-Chyuan Lin; Kang-Yun Lee; Chien-Da Huang; Chien-Ying Liu; Chun-Hua Wang; Han-Pin Kuo
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

9.  Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

Authors:  Li-Jun Ma; Su-Li Mao; Kevin L Taylor; Talerngsak Kanjanabuch; YouFei Guan; YaHua Zhang; Nancy J Brown; Larry L Swift; Owen P McGuinness; David H Wasserman; Douglas E Vaughan; Agnes B Fogo
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

10.  Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis.

Authors:  I Maruyama; M Nakata; K Yamaji
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

View more
  13 in total

1.  Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation.

Authors:  Woosuk S Hur; David S Paul; Emma G Bouck; Oscar A Negrón; Jean-Marie Mwiza; Lauren G Poole; Holly M Cline-Fedewa; Emily G Clark; Lih Jiin Juang; Jerry Leung; Christian J Kastrup; Tatiana P Ugarova; Alisa S Wolberg; James P Luyendyk; Wolfgang Bergmeier; Matthew J Flick
Journal:  Blood       Date:  2022-03-03       Impact factor: 22.113

2.  Both G protein-coupled and immunoreceptor tyrosine-based activation motif receptors mediate venous thrombosis in mice.

Authors:  Jean Marie N Mwiza; Robert H Lee; David S Paul; Lori A Holle; Brian C Cooley; Bernhard Nieswandt; Wyatt J Schug; Tomohiro Kawano; Nigel Mackman; Alisa S Wolberg; Wolfgang Bergmeier
Journal:  Blood       Date:  2022-05-26       Impact factor: 25.476

3.  Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission.

Authors:  B de Laat; M J M Traets; R W M De Laat-Kremers; S P Verweij; M Ninivaggi; E Jong; D Huskens; B A Blok; G C P Remme; A Miszta; R H T Nijhuis; G J M Herder; R Fijnheer; M Roest; A T L Fiolet; J A Remijn
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.752

4.  Fermented mulberry (Morus alba) leaves suppress high fat diet-induced hepatic steatosis through amelioration of the inflammatory response and autophagy pathway.

Authors:  Mi Rim Lee; Ji Eun Kim; Ji Won Park; Mi Ju Kang; Hyeon Jun Choi; Su Ji Bae; Young Whan Choi; Kyung Mi Kim; Jin Tae Hong; Dae Youn Hwang
Journal:  BMC Complement Med Ther       Date:  2020-09-18

Review 5.  Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks.

Authors:  Sarah Beck; Bernhard Hochreiter; Johannes A Schmid
Journal:  Front Cell Dev Biol       Date:  2022-03-17

6.  A novel ex vivo approach for measuring plasminogen activation upon established plasma clots.

Authors:  Jason S Palazzolo; Robert L Medcalf; Christoph E Hagemeyer; Be'eri Niego
Journal:  Res Pract Thromb Haemost       Date:  2022-07-21

7.  COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity.

Authors:  Emma G Bouck; Frederik Denorme; Alisa S Wolberg; Robert A Campbell; Lori A Holle; Elizabeth A Middelton; Antoinette M Blair; Bas de Laat; Joshua D Schiffman; Christian Con Yost; Matthew T Rondina
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-11-16       Impact factor: 8.311

8.  Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.

Authors:  Adam Miszta; Homa K Ahmadzia; Naomi L C Luban; Shuhui Li; Dong Guo; Lori A Holle; Jeffrey S Berger; Andra H James; Jogarao V S Gobburu; John van den Anker; Bas de Laat; Alisa S Wolberg
Journal:  J Thromb Haemost       Date:  2020-12-26       Impact factor: 5.824

Review 9.  Assessing Plasmin Generation in Health and Disease.

Authors:  Adam Miszta; Dana Huskens; Demy Donkervoort; Molly J M Roberts; Alisa S Wolberg; Bas de Laat
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

10.  Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity.

Authors:  Ze Zheng; Keiko Nakamura; Shana Gershbaum; Xiaobo Wang; Sherry Thomas; Marc Bessler; Beth Schrope; Abraham Krikhely; Rui-Ming Liu; Lale Ozcan; José A López; Ira Tabas
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.